| Line Item | 2022-04-30 | Y/Y |
|---|---|---|
| Revenue | $252.8M | +38.0% |
| Cost of Revenue | $63.7M | +43.1% |
| Gross Profit | $189.0M | +36.3% |
| R&D Expense | $150.5M | +118.6% |
| SG&A Expense | $61.0M | +84.4% |
| Operating Income | -$196.1M | -225.5% |
| Pre-tax Income | -$191.3M | -247.8% |
| Income Tax | $789K | +12.1% |
| Net Income | -$192.1M |
| Line Item | 2022-04-30 | Y/Y |
|---|---|---|
| Cash & Equivalents | $339.5M | +194.3% |
| Short-term Investments | $620.6M | -36.5% |
| Accounts Receivable | $80.3M | +22.6% |
| Current Assets | $1.06B | -9.6% |
| Total Assets | $1.17B | -2.1% |
| Current Liabilities | $150.2M | +20.6% |
| Total Liabilities | $181.4M | +34.1% |
| Line Item | 2022-04-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$86.5M | -130.2% |
| Capital Expenditures | $3.8M | +132.9% |
| Investing Cash Flow | $317.0M | +141.3% |
| Financing Cash Flow | $5.7M | -99.4% |
| Free Cash Flow | -$90.3M | -130.3% |
| -244.8% |
| Stockholders' Equity |
| $989.5M |
| -6.8% |